Biomedical Research

Jens Meiler, Distinguished Research Professor of Chemistry, was named the principal investigator for the project, in cooperation with 14 investigators across eight institutions. The team will work together to use advanced technology, including computational modeling, AI-driven predictions and structural biology, to develop a groundbreaking vaccine against all alphaviruses that offers long-lasting protection. Read More

Vanderbilt University expands its health care innovation role by joining the ARPA-H Customer Experience Hub as a spoke, aiming to advance patient-centric health care solutions. This is the second spoke designation with ARPA-H, underscoring Vanderbilt’s commitment to transformative health care research and accessibility for all Americans. Read More

In just over two years, a Vanderbilt-Neumora collaboration has led to the Phase 1 clinical trial of a treatment for schizophrenia spectrum disorders, which affect 3.7 million adults in the United States. This is the third chemical compound discovered at the Warren Center for Neuroscience Drug Discovery to reach Phase 1 clinical trials.     Read More

Vanderbilt University has been selected as an inaugural spoke for the ARPA-H Investor Catalyst Hub, a crucial component of the ARPANET-H initiative aimed at advancing accessible biomedical innovations. This partnership positions Vanderbilt to access potential funding and networking opportunities and provide input into ARPA-H’s health care research focus areas, aligning with their mission to accelerate equitable health care solutions nationwide. Read More

New research from the Office of Biomedical Research Education and Training connects the dots between career goals during graduate school and career outcomes, articulates how careers of Ph.D. alumni evolve during the 10 years after graduation. Read More

The U.S. federal government is preparing to launch a set of sweeping new regulations that will have a major impact on how biomedical researchers and social scientists work. It will require researchers to change how they get ethics approval, how they collect informed consent from participants, and more. Read More

During a meeting in Nashville last week, the director of the National Institutes of Health (NIH) called on academic medical centers to make the case for continued, strong federal investment in biomedical research. Read More